Navigation Links
Implantable devices to be powered by organosilicon compounds in the future

Medical technology has advanced so much to the extent of replacing lost organs or improving function of existing ones using artificial implants. These implantable devices are becoming commonplace today by serving as a good // alternative to the conventional treatment.

Such effective utilization would not have been possible without the availability of lithium batteries that supply power, thereby ensuring functionality of these tiny, yet useful devices. Designed to be extraordinarily reliable and work continuously for years, the batteries that power implantables are indispensable in everything from pacemakers to the electronic stimulators that help restore function in the brains of Parkinson's patients.

However, lithium batteries don't last forever and new surgery to maintain many devices seeded into the body is required. It is both a physical and financial strain for the patient. In an attempt to ensure superior performance, scientists are now working on silicon-based compounds that are used in the treatment of nervous and other disorders. The unique rechargeable ability of the new generation battery confers twice as longer lifetime than the ones currently used.

This offers a new ray of hope in medical treatment as these new generation electrical devices could be used to stimulate the nervous system, treat incontinence and overcome muscular impairment.

Central to that ability and vision, is emerging a new lithium battery technology, capable of making batteries smaller, last longer and, soon, accept a charge from outside the body without the need for surgery. "It turns out the organosilicon compounds (compounds made of silicon and other natural materials) are really good for improving lithium battery technology," says West, one instrumental behind this significant development. The new battery technology powers a "microstimulater" not much larger than a pencil lead and can be injected near target nerves to help overcome t he faulty nervous system wiring at the heart of Parkinson's, epilepsy and incontinence.

They're very flexible, stable, nonflammable, non-toxic and do not pose a threat to the environment, according to the researchers. The average expected life span of these batteries is expected to be over 12 years. Furthermore, it makes use of Silicon, one of the Earth's most abundant elements.

In addition to implantable devices for medicine, lithium batteries are used in scores of applications, from spacecraft to iPods. We will have to watch and wait for some time before the power of these batteries can be exploited to the maximum.
'"/>




Related medicine news :

1. Implantable Contact Lens Found Safe and Effective
2. New Implantable Device That Can Keep The Heart Ticking
3. Making MRIs Safe for Patients With Implantable Heart Devices
4. Combination therapy for patients treated with Implantable Cardioverter Defibrillator
5. New Implantable Cardioverter Defibrillators to avoid unnecessary shocks
6. First Implantable artificial heart gets FDA’s approva
7. Futuristic devices are here to take care of dental problems
8. Cheap Indian devices sought to treat sleep disorder
9. Bionic muscles developed by scientists powered by alcohol and hydrogen
10. Patients Empowered to Force for Better Services
11. China Introduces Solar-powered Baths
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... ... March 27, 2017 , ... Osteitis pubis may ... of groin injury, it occurs when the muscles around the pelvis become inflamed. ... around the lower torso, as well as accompanying tenderness and weakness. Without proper ...
(Date:3/27/2017)... Georgia (PRWEB) , ... March 27, 2017 , ... ... to announce that for a second year in a row; they are the ... healthcare designers in the industry voted on the award at Design Connections 2017. ...
(Date:3/27/2017)... ... ... The Anaheim Hills office accelerates and supports FNCC’s growth and further strengthens ... professionals over the past 6 months and is continuing to recruit new talent with ... of 2017. , “This new office is a direct result of our strong ...
(Date:3/27/2017)... ... March 27, 2017 , ... Golden Triangle Emergency Center will ... April 3rd to commemorate the two-year anniversary of the facility. The event will ... two great years while also familiarizing themselves with the facility. , In the ...
(Date:3/26/2017)... (PRWEB) , ... March 26, 2017 , ... ... worldwide to receive the RealSelf 100 Award, a prestigious award honoring the top ... procedures and to find and connect with doctors and clinics. , In 2016, ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... , March 27, 2017 Cota ... for value-based precision medicine, today announced the ... Novartis Pharmaceuticals Corporation to help improve clinical ... As part of this agreement, ... collaboration entered into January 2016, teams from ...
(Date:3/24/2017)... 2017 Research and Markets has announced ... report to their offering. ... The Cell Therapy Manufacturing Market, 2017-2027 ... of cell therapy manufacturing and focuses both on contract manufacturers ... are anticipated to emerge as viable alternatives to conventional treatment ...
(Date:3/24/2017)... Research and Markets has announced the addition of the "Global Wound ... report to their offering. ... The global wound care market was worth $24,482.9 million in 2015 and ... Among the various wound care products type, the advanced wound ... 2015. Among the various applications, surgical wound segment held the largest share ...
Breaking Medicine Technology: